LY-364947

LY-364947 Basic information
Product Name:LY-364947
Synonyms:LY 364947 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline;LY-364947, 396129-53-6;Transforming Growth Factor-β Type I Receptor Kinase Inhibitor;LY-364947;LY-364947, >=98%;LY364947;HTS466284; LY-364947;TGF-β RI Kinase Inhibitor;[3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole
CAS:396129-53-6
MF:C17H12N4
MW:272.3
EINECS:
Product Categories:API;Inhibitors;Smad;TGF-beta
Mol File:396129-53-6.mol
LY-364947 Structure
LY-364947 Chemical Properties
Melting point >230℃ (dec.)
Boiling point 490.8±45.0 °C(Predicted)
density 1.283±0.06 g/cm3(Predicted)
storage temp. 2-8°C
solubility DMSO: soluble2mg/mL, clear
pka8.94±0.50(Predicted)
form powder
color white to beige
Stability:Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.
InChIKeyIBCXZJCWDGCXQT-UHFFFAOYSA-N
Safety Information
Hazard Codes T,N
Risk Statements 25-36/37/38-50/53
Safety Statements 26-45-60-61
RIDADR UN 2811 6.1/PG 3
WGK Germany 3
HS Code 2933491090
MSDS Information
LY-364947 Usage And Synthesis
DescriptionLY-364947 (396129-53-6) is a selective ALK5 inhibitor, IC50 = 59, 400 and 1400 nM for TGF-β RI, TGF-β RII and MLK-7K, respectively.1 Inhibits Smad2 phosphorylation induced by TGF-β as well as fibronectin expression and MDA-MB-231 cell invasion.2 LY-364947 abolishes resistance of glioblastoma-initiating cells to radiation.3?Cell permeable.
UsesLY 364947, is a potent ATP-competitive inhibitor of Tgf-b signaling.
DefinitionChEBI: LY 364947 is a member of the class of pyrazoles carrying pyridin-2-yl and quinolin-4-yl substituents at positions 3 and 4 respectively. It has a role as a TGFbeta receptor antagonist. It is a member of pyrazoles, a member of pyridines and a member of quinolines.
Biological ActivitySelective inhibitor of TGF- β type-I receptor (TGF- β RI, TGFR-I, T β R-I, ALK-5) (IC 50 values are 59, 400 and 1400 nM for TGR- β RI, TGF- β RII and MLK-7K respectively). Inhibits TGF- β -dependent luciferase production in mink lung cells (p3TP lux) and growth in mouse fibroblasts (NIH 3T3) (IC 50 values are 47 and 89 nM respectively). Suppresses invasion of MDA-MB-231 breast cancer cells in a matrigel invasion assay.
Biochem/physiol ActionsLY-364947 is a selective, ATP-competitive inhibitor of Transforming Growth Factor-β Type I receptor kinase (TGF-β RI, ALK5) with IC50 = 59 nM. It is much less potent at related kinases, with IC50 = 400 nM for TGF-β RII and IC50 = 1400 nM for mixed lineage kinase-7 (MLK-7), a kinase in the MAP kinase signal pathway and closely related to TGF-β RII. LY-364947 inhibits TGF-β-dependent cellular growth (IC50 = 81 nM) in NIH 3T3 mouse fibroblasts.
in vitroly364947 was quickly identified as a potent inhibitor (ic50= 51 nm) and was chosen as a platform for sar development. compounds were further evaluated as inhibitors of tgf-β-dependent luciferase production in mink lung cells (p3tp lux) and growth in mouse fibroblasts (nih 3t3) [1].
in vivoin a rat model of nmda-induced retinal degeneration, simultaneous injection of nmda and the tgf-β inhibitor ly364947 slightly but significantly attenuated the reduction in number of cells in the ganglion cell layer and almost completely prevented the enhancement of capillary degeneration. [3].
storageStore at RT
References1) Sawyer?et al. (2003),?Synthesis and activity of new aryl-and hetero-aryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain; J. Med. Chem.,?46?3953 2) Shiou?et al. (2006),?Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta; J. Biol. Chem.,?281?33971 3) Hardee?et al. (2012),?Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β; Cancer Res.,?72?4119
LY-364947 Preparation Products And Raw materials
Raw materials2-(quinolin-4-yl)-1-(pyridin-2-yl)-ethanone-->Methyl picolinate-->4-methylquinoline
LY 294002 HYDROCHLORIDE (S)-3-fluoro-4-(4-((2-(3-fluorophenyl)pyrrolidin-1-yl)methyl)phenoxy)benzamide SB525334 LY 88074 LY2409881 trihydrochloride LY 2784544 2-METHOXYESTRADIOL LY2584702 LY3214996 2-(4-((4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)oxy)pyridin-2-yl)amino)pyridin-2-yl)propan-2-ol SB 431542 Etalocib LY2228820 LY2828360 N-[(4-METHYLPHENYL)SULPHONYL]-3-(PYRIDIN-2-YL)-4-(QUINOLIN-4-YL)PYRAZOL-1-CARBOXAMIDE LY-364947 3-(PYRIDIN-2-YL)-4-(QUINOLIN-4-YL)-1-(TERT-BUTYLCARBONYL)PYRAZOLE N-ETHYL-3-(PYRIDIN-2-YL)-4-(QUINOLIN-4-YL)PYRAZOL-1-CARBOXAMIDE

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.